Dapsone and schistocytes: Thrombotic microangiopathy or not?
Alexis Archambeaud, Cédric Aumont, Claire Pouplard, Marie-Sarah Agier, François Maillot, Jean-Michel Halimi, Adrien Bigot · 2026
Read Dapsone and schistocytes: Thrombotic microangiopathy or not? by Alexis Archambeaud, Cédric Aumont, Claire Pouplard, Marie-Sarah Agier, François Maillot, Jean-Michel Halimi, Adrien Bigot (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13196926.txt.
Description
Alexis Archambeaud and colleagues published a 2026 review of past cases on dapsone and red cell damage. Dapsone is a drug used for leprosy and some skin and immune diseases. It can break down red blood cells, yet broken cell fragments called schistocytes are not expected in that process.
The team reviewed adults treated at one French hospital over sixteen years. Of 19 patients with blood smear tests, ten had schistocytes in their blood. Those patients had sharper drops in blood counts and stronger signs of cell breakdown. No organ failure was found in the records. The fragments cleared within days once the drug stopped. Whether this pattern can harm organs needs more study.
Catalog record
| CREATOR | Alexis Archambeaud, Cédric Aumont, Claire Pouplard, Marie-Sarah Agier, François Maillot, Jean-Michel Halimi, Adrien Bigot |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |